Re-Taking the Pulse® US - DRG conducted an omnibus survey in July to understand how physicians' behaviors and preferences are changing in response to the COVID-19 pandemic. We tracked changes in use of traditional and emerging channels, including telehealth, remote detailing, and attitudes towards digital resources.
The study was fielded among U.S. Oncologists which includes Med-Oncs n=31 & Hem-Oncs n=30 in July 2020.
Questions answered in this report:
- How can pharmas differentiate their messaging through curated multichannel tactics during COVID-19?
- How are emerging channels (e.g. voice, telehealth, etc.) reshaping physicians workflow during COVID-19?
- How can pharma boost physician engagement with their personal promotion and online channels as physicians move to remote care, e.g., pharma sales reps, pharma owned HCP websites, and sponsored content on third-party websites and social media?